Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ocular hypertension | D009798 | EFO_1001069 | H40.0 | — | 7 | — | — | — | 7 |
Glaucoma | D005901 | EFO_0000516 | H40 | — | 6 | — | — | — | 6 |
Hypertension | D006973 | EFO_0000537 | I10 | — | 4 | — | — | — | 4 |
Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | — | 3 | — | — | — | 3 |
Drug common name | VEROSUDIL |
INN | verosudil |
Description | Verosudil (AR-12286) is a drug which acts as a potent and selective inhibitor of the enzyme Rho kinase, and has been investigated for the treatment of glaucoma.
|
Classification | Small molecule |
Drug class | vasodilators (undefined group): Rho protein kinase (ROCK) inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN(C)C(C(=O)Nc1ccc2c(=O)[nH]ccc2c1)c1ccsc1 |
PDB | — |
CAS-ID | 1414854-42-4 |
RxCUI | — |
ChEMBL ID | CHEMBL3545065 |
ChEBI ID | — |
PubChem CID | 66906051 |
DrugBank | — |
UNII ID | MAF34143WM (ChemIDplus, GSRS) |